Physician profile
Mark R Traill
NPI 1972555308
$61,823.58
in general payments reported to CMS, 2019-2025
4 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,229 · 2020: $16K · 2021: $11K · 2022: $12K · 2023: $11K · 2024: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Travel and Lodging: $843 · Food and Beverage: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,327.43 |
| Travel and Lodging | $842.90 |
| Food and Beverage | $100.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Icad, INC | $51,933.63 | 2019-2024 | Axxent Surface Controller, Powerlook Amp Pro With Secondlook Digital |
| Bayer Healthcare LLC | $7,908.09 | 2024 | |
| Ge Healthcare | $1,881.00 | 2021 | |
| Siemens Medical Solutions USA, INC. | $100.86 | 2023 | Mammomat Revelation |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Traill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.